Mr. Seri has over 25 years of profound experience in the global pharma and API industry. He had previously served as an EVP and head of Sun Pharma’s API business, CEO of New Pharm and held various roles with extensive experience in global commercial, operations and quality management at Teva Pharmaceuticals’ API Division.
Mr. Seri holds a B.Sc. and M.Sc. in Biology from Ben-Gurion University and an M.B.A from the Interdisciplinary Center Herzliya.